THE IMPORTANCE OF CHEMOTHERAPY IN THE
MANAGEMENT STRATEGIES REGARDING
HEPATIC METASTASES IN COLORECTAL
CANCER
OCTAV GINGHINĂ1, GEORGE TRAIAN ALEXANDRU BURCEA
DRAGOMIROIU2, CAROLINA NEGREI3*, MARIA BÂRCĂ2
1”Sf. Ioan” Hospital, Department of Oncological Surgery, “Carol
Davila” University of Medicine and Pharmacy, Faculty of Dental
Medicine, 13, Vitan-Barzesti Street, 042122, Bucharest, Romania
2Department of Drug Control, “Carol Davila” University of Medicine
and Pharmacy, Faculty of Pharmacy, 6, Traian Vuia Street, 020956,
Bucharest, Romania
3Department of Toxicology, “Carol Davila” University of Medicine and
Pharmacy, Faculty of Pharmacy, 6, Traian Vuia Street, 020956,
Bucharest, Romania
* corresponding author: carol_n2002@hotmail.com
Download Full Article

Abstract:

The liver is the most common site for haematogenous metastases in colorectal cancer. Over the past ten years the survival rate in patients with hepatic metastases has significantly improved, mostly because of the development of new chemotherapy protocols, as well as new therapeutic agents. Overall, these are strengthening the effects of surgery, which in case of radical resection offers the best survival. Moreover, surgical control of liver metastatic extensive disease can combine resection with ablation therapies or staged methods.
Today, the treatment of colorectal cancer liver metastases is essentially multidisciplinary, the medical oncologist together with the surgeon and the gastro-enterologist deciding the therapeutical sequence individualised for each patient.

Top